Cost Saving Biquelle Temp2018-08-29T11:15:45+00:00

queloxlogo400

HEALTHCARE PROFESSIONALS

[LayerSliderWP] Slider not found

[LayerSliderWP] Slider not found

Save 56% of the cost of category C quetiapine XL  prescriptions by prescribing Biquelle XL.2

50percentpigquel

Quetiapine XL currently costs the NHS over £65.5 million per annum.1

By prescribing Biquelle XL by brand, the average savings for a CCG will be more than £172,200 per year providing the NHS with a total annual prescribing cost saving of over £36.3 million per year.1

queloxXLlogo400

 

 

Biquelle XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • 56% saving on Category C Drug Tariff prices;2
  • Available from mainline wholesalers;
  • High level of stockholdings;
  • Price guaranteed till 2019;3
  • Bioequivalent to the originator.

letter Download Supply Guarantee Letter           Download Price Guarantee Letter

ProductCategory C UK Drug Tariff price2Biquelle XL Price
Quetiapine prolonged-release tablets 50mg x 60 £67.66 £29.45
Quetiapine prolonged-release tablets 150mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 200mg x 60£113.10 £49.45
Quetiapine prolonged-release tablets 300mg x 60£170.00£74.45
Quetiapine prolonged-release tablets 400mg x 60£226.20 £98.95

References: 1) Based on IMS Health BPI Data September 2013 – August 2014 for 211 CCGs switching to Biquelle XL. 2) Drug Tariff England and Wales December 2014. 3) Price guarantee subject to no material change to the products or Category C until the 2019 PPRS review.

[LayerSliderWP] Slider not found

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Biquelle XL, please see the full prescribing information.
Revision reference – Biquelle XL_11_19/10/2016

[LayerSliderWP] Slider not found

Save

Save

Save

Save

Save

Save

Save